R-CMOP in Patients With Newly Diagnosed Diffuse Large B-cell Lymphoma

NCT06594640 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

108

Enrollment

OTHER

Sponsor class

Conditions

Diffuse Large B-cell Lymphoma

Interventions

DRUG: Mitoxantrone Hydrochloride Liposome
DRUG: Rituximab (R)
DRUG: Cyclophosphamide (CTX)
DRUG: Vincristin
DRUG: Prednisolone

Sponsor

Institute of Hematology & Blood Diseases Hospital, China